Avanafil – Getting the Best out of ED Drug Characteristics

One of the things or condition that a man would really hate to have is erectile dysfunction.  Often time, this is a condition that makes a man not feel like a man because the main reason he is called a man to begin with is not useable.  Most men who suffer from this condition tend to keep it to themselves, mainly because it is an embarrassing condition to have.  Fortunately for men who have this condition these days, they have the internet to turn to regarding their problem. Read more…

Future looks bleak for Avandia as safety trial put on hold

Last week saw an rule that there is reason to believe the troubled diabetes drug Avandia (rosiglitazone) does indeed increase cardiovascular risks compared to its direct competitor Actos (pioglitazone).

Now, the FDA appears to be moving to shut down the Canadian-led trial that represented the last chance for maker GlaxoSmithKline to prove its drug is safe. The agency put a "partial clinical hold" on new recruitment for the trial while it updates the lead investigators - Drs Salim Yusef and Hertzel Gerstein of McMaster University - on the results of last week's panel meeting.

While the FDA safety panel stopped short of voting to remove Avandia from the market, the agency can still take action without a vote, and most observers suspect the end is near for Avandia, which has already seen sales collapse in the wake of data suggesting it increases cardiovascular events.

In fact, the same safety concerns were inhibiting recruitment to the TIDE trial. GSK, which agreed in 2007 to fund a head-to-head comparison with pioglitazone, said last week that only 1,100 of an intended 16,000 study participants have volunteered to date.

1 comments:

sharon(aka Purley Quirt ) said...

I would like to see/know who is behind the thrust to use diabetes medication as a prophylactic measure ( including insulin).

Is this ever increasing drug dependent society ( at every level) ever going to ask who is behind it?

I am very intrigued by this new push by pharmacia to make physicians feel the time they spend on alternates to drugs ( teaching, training, lifestyle change)is a sign of ? failing to serve the best interests of the patient .